2023 annual financial data
Emergent BioSolutions 2023 Operating margin
Emergent BioSolutions 2023 operating margin with verified reported values.
Direct answer
Operating margin was -69.23%.
Operating income was -726,400,000 USD and net income was -760,500,000 USD.
Operating cash flow was -206,300,000 USD.
Get free Emergent BioSolutions email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,049,300,000 USD
- Operating income
- -726,400,000 USD
- Net income
- -760,500,000 USD
- Operating cash flow
- -206,300,000 USD